drugset / Trial / NCT00134186
Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if renal cell (kidney) cancer that has spread to other parts of the body will respond to treatment with motexafin gadolinium (MGd).
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | motexafin gadolinium | Diagnostic / imaging agent | — | — |